MCOLN2 and glioblastoma: Therefore, whether the increased aggressiveness of DN GBM cells was associated with an enhanced survival of DN cells compared to single TRPML1- and TRPML2-silenced GBM cells was evaluated in vitro at 48 h after transfection by an MTT assay.